Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in refractory schizophrenia
RBR-4yr9mtPhase 4Not yet recruiting
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxytocin in schizophrenia (6 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoints: Endogenous plasma oxytocin levels, Acute effects of single-dose intranasal oxytocin and 1 more. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on RBR-4yr9mt.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4yr9mt.